Access to Surgery and Outcomes for Papillary Thyroid Cancer Following the 2015 American Thyroid Association Guideline Changes
The American Surgeon™ · 2026-09 · 92 (9) · 2420-2428
DOI: 10.1177/00031348261455092 ↗Kurz gefasst
Leitlinie in der Zeitschrift The American Surgeon™, online erschienen am 21.05.2026. Verfasst von Laura M Cogua und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of School of Medicine, Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA. Hauptthemen laut MEDLINE: Thyroidectomy, Thyroid Neoplasms, Thyroid Cancer, Papillary, Practice Guidelines as Topic. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
The extent of surgical treatment for intermediate-sized (1.0-4.0 cm) papillary thyroid cancer (PTC) has been widely debated. This study evaluates the impact of the 2015 ATA guidelines on the surgical treatment trends of intermediate-sized PTC tumors.
Methods
Using the Surveillance, Epidemiology, and End Results (SEER) database, patients with intermediate-sized PTC tumors were separated into pre-ATA guideline changes (2000-2015) or post-ATA changes (2016-2020) groupings. Lobectomy or total thyroidectomy usage was compared with logistic regression analyses.
Results
The rate of lobectomy increased from a mean usage rate of 10.0% pre-ATA updates to 18.6% post-guideline changes ( P < 0.001). Logistic regression showed the rate of thyroidectomy decreased post-ATA changes ( P < 0.001, odds ratio (OR) = 0.607). Additionally, total thyroidectomy was associated with improved survival ( P < 0001, HR = 0.624) and); tumors sized 2.1 cm-3.0 cm ( P < 0001, HR = 1.824) and 3.1 cm-4.0 cm ( P < 0001, HR = 2.927) were associated with worse survival.
Conclusions
After the 2015 ATA guideline changes there has been a significant increase in the rate of lobectomy for intermediate-sized PTC tumors occurred after the 2015 ATA guideline changes, reflecting the guidelines supporting less aggressive surgical management in low-risk cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of School of Medicine, Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA.
- Department of Orthopedic Surgery, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, USA.
- Department of Internal Medicine, Division of Hematology/Oncology, Creighton University Medical Center, Omaha, NE, USA.
- Department of Surgery, Division of Endocrine Surgery, Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA.
- Department of Otolaryngology and Skull Base Surgery, Barrow Neurological Institute, Phoenix, AZ, USA.
ORCID-Profile: Laura M Cogua
Zitieren
APA
Cogua, L. M., Tupper, C. J., Silberstein, P. T., Coan, K. E., & Jategaonkar, A. A. (2026). Access to Surgery and Outcomes for Papillary Thyroid Cancer Following the 2015 American Thyroid Association Guideline Changes. The American Surgeon™, 92(9), 2420-2428. https://doi.org/10.1177/00031348261455092
Vancouver
Cogua LM, Tupper CJ, Silberstein PT, Coan KE, Jategaonkar AA. Access to Surgery and Outcomes for Papillary Thyroid Cancer Following the 2015 American Thyroid Association Guideline Changes. The American Surgeon™. 2026;92(9):2420-2428. doi:10.1177/00031348261455092
BibTeX
@article{Cogua2026,
author = {Cogua, Laura M and Tupper, Connor J and Silberstein, Peter T and Coan, Kathryn E and Jategaonkar, Ameya A},
title = {Access to Surgery and Outcomes for Papillary Thyroid Cancer Following the 2015 American Thyroid Association Guideline Changes},
journal = {The American Surgeon™},
year = {2026},
volume = {92},
number = {9},
pages = {2420--2428},
doi = {10.1177/00031348261455092}
}
EUVIMED